Search clinical trials for: Mycophenolate acid

Total 23784 results

Novartis Pharmaceuticals

Completed

Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance

Renal Transplantation

United States
Novartis Pharmaceuticals

Terminated

A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms

Renal Transplantation

United States
Centre Hospitalier Universitaire de Saint Etienne

Completed

Pharmacokinetic Evaluation of an Intensified and Decreasing Dosing Regimen of Mycophenolate Sodium in Combination With Tacrolimus Post Kidney Transplant: The Myfortic Study

Kidney Transplantation

France
Irmandade Santa Casa de Misericórdia de Porto Alegre
Novartis

Completed

A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) (AUC-MPA)

Renal Transplantation

Brazil
Nanjing University School of Medicine

Completed

Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN

Nephritis | Henoch-Schoenlein Purpura

China
Nanjing University School of Medicine

Completed

MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis

Vasculitis | Anti-Neutrophil Cytoplasmic Antibody

China
University of Pennsylvania
Novartis Pharmaceuticals

Terminated

Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

Transplants and Implants

United States
Novartis

Completed

Gastrointestinal and Health-related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil

Maintenance Kidney Transplant

Switzerland
Panacea Biotec Ltd

Completed

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

Healthy Volunteers

India
Teva Branded Pharmaceutical Products R&D, Inc.
Parexel

Terminated

Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

Stable Renal Transplant Recipients
Panacea Biotec Ltd

Completed

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition

Healthy Volunteers

India
Fred Hutchinson Cancer Center
University of Washington

Completed

MMF for HIV Reservoir Reduction

Human Immunodeficiency Virus I Infection

United States
Oklahoma Medical Research Foundation
NYU Langone Health

Completed

Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis

Arthritis | Systemic Lupus Erythematosus

United States
Columbia University
Pfizer; Cornell University

Completed

Using mTOR Inhibitors in the Prevention of BK Nephropathy

BK Viremia | BK Nephropathy

United States
Samsung Medical Center

Unknown

Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept (NODAT)

Diabetes

Korea, Republic of
University of Giessen
Novartis; Hoffmann-La Roche; Astellas Pharma Inc; Heidelberg University

Completed

Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy

Polyomavirus Infections

Germany
Novartis Pharmaceuticals

Completed

Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation

Renal Transplant

United Kingdom
Hoffmann-La Roche
Aspreva Pharmaceuticals

Completed

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)

Pemphigus Vulgaris (PV)

Turkey, Switzerland, United States, Germany, United Kingdom, Ukraine, Israel, Canada
University of Utah

Completed

Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State

Kidney Transplantation

United States
The Third Affiliated Hospital of Southern Medical...

Unknown

The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear

Lupus Nephritis

China
Chong Kun Dang Pharmaceutical

Completed

Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients (My-Rept_KT_P4)

Kidney Transplantation

Korea, Republic of
Children's Hospital of Fudan University
Shanghai Children's Hospital; Shanghai Children's Medical Center; Xinhua Hospital...

Withdrawn

Randomized Trial Evaluating Mycophenolate Mofetil in Children With Nephrotic Syndrome After Rituximab Treatment

Steroid-Dependent Nephrotic Syndrome | Frequently Relapsing Nephrotic Syndrome

China
R. Mark Ghobrial, MD
Novartis

Completed

Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation

End Stage Liver Disease

United States
University of Miami
Novartis Pharmaceuticals

Completed

Myfortic vs. Cellcept in Kidney Transplant Recipients

End Stage Renal Disease

United States
Region Skane

Completed

Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis (MMFSSC)

Systemic Sclerosis | Gastrointestinal Complication

Sweden
Klemens Budde
Novartis Pharmaceuticals

Completed

Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS

Immunosuppression | Transplantation | Drug Interaction

Germany
Asan Medical Center

Unknown

TO Compare the Triple Drug Therapy and Dual Therapy . (OPTIMUS-A)

HEPATITIS

Korea, Republic of
Lingyun Sun

Unknown

Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN)

Lupus Nephritis

China
University of Washington
Genentech, Inc.

Completed

Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant

Diabetic Nephropathies | Kidney Failure, Chronic | Glomerulonephritis, IGA | Hypertension, Renal
Medical University of South Carolina
Hoffmann-La Roche

Terminated

Mycophenolate for Pulmonary Sarcoidosis

Pulmonary Sarcoidosis

United States
Seoul National University Hospital
National Institute of Food and Drug Safety Evaluation (Republic of Korea)

Recruiting

Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation

Korea, Republic of
Chulalongkorn University
Berlin Pharmaceutical Industry

Terminated

Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis

Lupus Nephritis

Thailand
Columbia University

Completed

Study of CellCept for Advanced Pancreatic Cancer

Pancreatic Cancer

United States
King Faisal Specialist Hospital & Research Center

Unknown

Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Saudi Arabia
Children's Hospital Medical Center, Cincinnati

Withdrawn

Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis (PRUNE)

Lupus Nephritis
Novartis

Completed

Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant

Kidney Transplantation

Brazil
Emory University

Terminated

Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept

Cardiac Transplantation

United States
University Hospital, Limoges
Hoffmann-La Roche

Unknown

Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients

Kidney Transplant Recipients

France
Ajou University School of Medicine

Completed

Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation

Disorder Related to Renal Transplantation

Korea, Republic of
Lindenwood University
NNB Nutrition

Completed

A Pilot Study to Determine the Bioavailability of Oral Beta-Aminoisobutyric Acid (BAIBA) Ingestion (BBA)

Absorption; Chemicals

United States
University of Toronto

Completed

Protein Requirements in Male and Female Endurance Athletes

Healthy | Increased Metabolic Requirement

Canada
Vedic Lifesciences Pvt. Ltd.

Completed

Clinical Study to Evaluate Safety and Efficacy of Amino Acid in Healthy Individuals

Safety and Efficacy

India
University of Toronto
Ajinomoto Co., Inc.

Completed

Protein Requirements In Active Female Populations

Healthy | Increased Metabolic Requirement
Galmed Medical Reserch

Completed

A Phase 1 Single and Multiple-Dose Study of Aramchol in Healthy Male Volunteers

Healthy

Israel
Mirum Pharmaceuticals, Inc.

Completed

Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis

Bile Acid Synthesis Defect

United States
University of South Florida
National Cancer Institute (NCI); Children's Oncology Group

Completed

Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer

Sarcoma | Lymphoma | Kidney Cancer | Leukemia | Neurotoxicity | Peripheral Neuropathy

United States
Clinical Hospital Merkur
University Hospital Rijeka; University Medical Centre Ljubljana

Completed

Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis

Kidney Transplantation | Kidney Failure

Croatia
Novartis Pharmaceuticals

Active, not recruiting

Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis

Lupus Nephritis

Taiwan
University of California, San Francisco

Withdrawn

Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk (STIFLE-RISK)

Infection | Transplant;Failure,Kidney

United States
Roxane Laboratories

Completed

Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Prophylaxis of Organ Rejection

United States

Search clinical trials for: Mycophenolate acid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations